<DOC>
	<DOCNO>NCT00579514</DOCNO>
	<brief_summary>The basic premise research proposal determine whether significant association germline polymorphism cancer colon , bladder , breast , testicular , prostate , ovary , kidney , lung , lymphoid organ , head neck . This exploratory study design generate hypothesis research .</brief_summary>
	<brief_title>Germline Alterations Tumor Susceptibility Genes New York Cancer Patients</brief_title>
	<detailed_description>To establish significant correlation genetic polymorphism cancer , largescale , systematic comparison genetic alteration utilize case-control methodology propose . To date , study limit due large number sample necessary obtain statistical significance , lack rapid accurate method screen genetic polymorphism . We propose utilize anonymized design obtain DNA residual material routine diagnostic blood test , link sample limit set clinical variable , test frequency candidate low-penetrance cancer susceptibility allele . These data combine similar data control group age- ethnically-matched volunteer relate cohort study conduct separately . Polymorphisms screen include involve gene PTEN , APC , TGF Î²R-I , BLM , CHK2 , p85 phosphoprotein , ATM , ER , PR , MCP-1 , MPIF , CCR2/5 , CCR3 , SULT1A1 . Cancers include breast , bladder , kidney , colon , testicular , lung , prostate , ovarian , lymphoid neoplasm , head neck carcinoma . Genes SNPs know relevant either development treatment lymphoid malignancy also target . Specifically , candidate gene select 1 ) cytokine signal , 2 ) DNA repair , 3 ) apoptosis regulatory pathway .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<criteria>Patients histologic diagnosis cancer colon , breast , bladder , kidney , testicle , lung , prostate , head neck , lymphoid organ , donate diagnostic blood sample either inpatient outpatient MSKCC . All patient two histologic diagnosis primary tumor type involve site . Patients Ashkenazi Jewish ancestry histologic diagnosis cancer type . Samples ascertain part protocol 98024A ( 1 ) also eligible ascertainment study . MSKCC patient without histologic diagnosis cancer breast , bladder , kidney , colon , testicle , lung , prostate , lymphoid malignancy ( include type lymphoma ) eligible AMDeC sponsor component study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>